The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis

基于密度直方图的计算机化综合指数(CII)可预测特发性肺纤维化的死亡率

阅读:1

Abstract

Quantitative assessment of the extent of radiological alterations in interstitial lung diseases is a promising field of application that goes beyond the limitations of qualitative scoring. Analysis of density histograms, i.e., skewness, kurtosis, and mean lung attenuation, is among the most studied approaches. We recently proposed their integration in a single parameter, the computerized integrated index (CII), to reduce their redundancy. The CII has proven effective in detecting subclinical lung involvement, correlates with lung function/disease activity, and predicts mortality in systemic sclerosis patients. Seventy-three newly diagnosed and therapy-naive IPF patients (M = 50; median age: 70.2 years) were prospectively enrolled from January 2014 to December 2022, and followed till December 2023. At baseline, all underwent lung function testing and volumetric high resolution chest CT. Density histograms were analyzed with an open-source automatic platform (Slicer 3D) and CII derived by means of Principal Component Analysis, as previously described. During a median follow-up of 5.8 years, 39 (53.4%) subjects died. Median overall survival (OS) was 4.9 years (95% CI 3.7 years-not estimable). The CII was significantly associated with OS (HR 0.49; 95% CI 0.35-0.68; P < 0.001) and correlated with lung function (r = 0.41; 95% CI 0.19 to 0.60; P < 0.001 for FVC, and r = 0.62; 95% CI 0.44 to 0.75; P < 0.001 for DLCO(sb)). Patients stratification according to CII tertile, showed a consistent reduction in the hazard of death. After adjusting for body mass index, smoking, GAP stage, and anti-fibrotic therapy, the CII preserved a significant association with the hazard of death (HR 0.35; 95% CI 0.2-0.63; P < 0.001). CII is a proxy marker of IPF severity worthy of use for prognostication purposes in daily practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。